Table 1: Clinical data comparison for 2 groups of patients.

Prevention Group Control Group
Case Number 21 22
Male 8 9
Female 13 13
Age(year) 45.9 47.3
Tumor Type
Non-Hodgkin's lymphoma 6 6
Breast Cancer 4 4
Non-small cell lung cancer 4 5
Small cell lung cancer 2 1
Colorectal cancer 2 3
Stomach cancer 2 2
Ovarian cancer 1 1
Tumor Stage
II 8 8
III 7 8
IV 6 6
Before chemotherapy
HBeAg (+) 12 14
HBeAg (-) 9 8
ALT (U/L) 30.49 ± 8.62 31.25 ± 9.14
TSB (µmol/L) 16.51 ± 4.68 15.03 ± 5.17
HBV-DNA (+) 71.4% (15/21) 72.7% (16/22)
Serum HBV-DNA levels (after a Log conversion) 3.47 ± 1.82 3.39 ± 1.73